Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: A phase II study - Preliminary results

被引：0
|
作者：
Chougule, P
Wanebo, H
Akerley, W
McRae, R
Nigri, P
Leone, L
Safran, H
Ready, N
Koness, RJ
Radie-Keane, K
Cole, B
机构：
[1] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Radiat Oncol, Providence, RI 02903 USA
[2] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med Oncol, Providence, RI 02903 USA
[3] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Otolaryngol, Providence, RI 02903 USA
[4] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg Oncol, Providence, RI 02903 USA
[5] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Biostat, Providence, RI 02903 USA
[6] Brown Univ, Roger Williams Med Ctr, Sch Med, Providence, RI 02903 USA
[7] Brown Univ, Vet Adm Med Ctr, Sch Med, Providence, RI 02903 USA
[8] Brown Univ, Miriam Hosp, Sch Med, Providence, RI 02903 USA
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S57 / S61
页数：5
相关论文
共 50 条
  • [31] Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer
    Karasawa, K
    Shinoda, H
    Katsui, K
    Seki, K
    Kohno, M
    Hanyu, N
    Nasu, S
    Muramatsu, H
    Maebayashi, K
    Mitsuhashi, N
    Yoshihara, T
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3785 - 3788
  • [32] Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma
    Carter, Dennis L.
    Asmar, Lina
    Barrera, David
    Caracandas, John
    Dakhil, J. Shaker
    McCracken, Dean
    O'Rourke, Mark A.
    Rosenberg, Richard K.
    Boehm, Kristi A.
    Ilegbodu, Des
    Reid, Robert L.
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (05) : 473 - 481
  • [33] Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma
    Dennis L. Carter
    Lina Asmar
    David Barrera
    John Caracandas
    J. Shaker Dakhil
    Dean McCracken
    Mark A. O’Rourke
    Richard K. Rosenberg
    Kristi A. Boehm
    Des Ilegbodu
    Robert L. Reid
    Investigational New Drugs, 2008, 26 : 473 - 481
  • [34] A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN)
    Karapanagiotou, E. M.
    Chester, J. D.
    Pandha, H. S.
    Gill, G. M.
    Coffey, M. C.
    Mettinger, K.
    Harrington, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Preoperative concurrent paclitaxel, carboplatin and radiotherapy in advanced operable cancer of the oropharynx and oral cavity: A phase II evaluation
    Eckhardt, A
    Wildfang, I
    Karstens, JH
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S174 - S174
  • [36] Phase II study of capecitabine in combination with cisplatin in advanced head and neck cancer: Preliminary results
    Lorusso, V.
    Calvi, N.
    Ciccarese, M.
    Romano, G.
    Palumbo, A.
    Bonaduce, S.
    Santantonio, M.
    Latorre, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Concomitant chemo-radiotherapy (chemo-CAIR) in patients with advanced head and neck cancers - early results of phase II study
    Sasiadek, W
    Golen, M
    Rutkowski, T
    Wygoda, A
    Sygula, M
    Plecki, B
    Przeorek, W
    Hejduk, B
    Kolosza, Z
    Skladowski, K
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S314 - S314
  • [38] Phase II study of capecitabine in combination with cisplatin in advanced head and neck cancer: preliminary results
    Lorusso, V
    Calvi, N.
    Ciccarese, M.
    Romano, G.
    Palumbo, A.
    Bonaduce, S.
    Santantonio, M.
    Latorre, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 191 - 191
  • [39] Interim Report of a Phase II Study of Lapatinib and Concurrent Radiotherapy in Patients With Locally Advanced Head and Neck Cancer
    Bavan, B.
    Krakow, T.
    Pinto, H.
    Harari, P.
    Brizel, D.
    Amdur, R.
    Hu, K. W.
    Le, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S535 - S535
  • [40] Carboplatin, tegafur-uracil, leucovorin and concurrent radiotherapy for locally advanced head and neck squamous cell carcinoma. Results of the 2003-01 phase II GORTEC study
    Fesneau, M.
    Chapet, S.
    Martin, L.
    Pommier, P.
    Alfonsi, M.
    Laguerre, B.
    Feham, N.
    Berger, C.
    Calais, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S423 - S423
12345